國立虎尾科技大學 |

Personalization in Gynecologic Oncology

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	Personalization in Gynecologic Oncology/ edited by Masaki Mandai.
其他作者:	Mandai, Masaki.
面頁冊數:	V, 147 p. 16 illus., 10 illus. in color.online resource. :
Contained By:	Springer Nature eBook
標題:	Tumour Biomarkers. -
電子資源:	https://doi.org/10.1007/978-981-19-4711-7
ISBN:	9789811947117

Personalization in Gynecologic Oncology
Personalization in Gynecologic Oncology[electronic resource] /edited by Masaki Mandai. - 1st ed. 2022. - V, 147 p. 16 illus., 10 illus. in color.online resource. - Comprehensive Gynecology and Obstetrics,2364-219X. - Comprehensive Gynecology and Obstetrics,.

1 Personalized treatment in ovarian cancer -- 2 Carcinogenesis and personalization in hpv-associated precancer lesions of the cervix -- 3 Personalized treatment for gestational trophoblastic tumor -- 4 Personalized treatment in uterine sarcoma -- 5 Clinical relevance of brca1/2 pathogenic variants and impaired dna repair pathways in ovarian carcinomas -- 6 Personalized treatment in immunotherapy for gynecologic cancer -- 7 Risk assessment and prevention strategies for hereditary gynecological cancers -- 8 How genome-wide analysis contributes to personalized treatment in cancers including gynecologic cancers -- 9 Personalized treatment of gynecological cancer according to age and symptom benefit.

This book thoroughly illustrates the designed and tailored medical approaches for tumors of the female reproductive organ. The chapters explore different cancer species such as ovarian cancer, endometrial cancer, cervical cancer, etc. Various treatment modalities such as immunotherapy and histotype-specific treatment are delivered, and it offers a chapter on how genome-wide analysis contributes to personalized treatment. It is essential to understand this concept because many molecular target drugs and the prevalence of genome-based analysis in clinical settings have enabled us to introduce valid precision medicine in the field of gynecologic oncology. Chapters explain the stream of transition from conventional standardized treatment to personalized treatment and address future perspectives. Personalization Gynecologic Oncology is a well-designed source for beginning to advanced oncologists, gynecologists, geneticists, genetic counselors, and nurses. Offering the latest treatment strategies, the Editor hopes the ideas presented here will be a foundation for further development in the field. .

ISBN: 9789811947117

Standard No.: 10.1007/978-981-19-4711-7doiSubjects--Topical Terms:

1391075
Tumour Biomarkers.

LC Class. No.: RC254-282

Dewey Class. No.: 616.994

Personalization in Gynecologic Oncology
LDR:03196nam a22004095i 4500 001 1084715
003 DE-He213
005 20221025170704.0
007 cr nn 008mamaa
008 221228s2022 si | s |||| 0|eng d
020 $a 9789811947117 $9 978-981-19-4711-7
024 7 $a 10.1007/978-981-19-4711-7 $2 doi
035 $a 978-981-19-4711-7
050 4 $a RC254-282
072 7 $a MJCL $2 bicssc
072 7 $a MED062000 $2 bisacsh
072 7 $a MJCL $2 thema
082 0 4 $a 616.994 $2 23
245 1 0 $a Personalization in Gynecologic Oncology $h [electronic resource] / $c edited by Masaki Mandai.
250 $a 1st ed. 2022.
264 1 $a Singapore : $b Springer Nature Singapore : $b Imprint: Springer, $c 2022.
300 $a V, 147 p. 16 illus., 10 illus. in color. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
490 1 $a Comprehensive Gynecology and Obstetrics, $x 2364-219X
505 0 $a 1 Personalized treatment in ovarian cancer -- 2 Carcinogenesis and personalization in hpv-associated precancer lesions of the cervix -- 3 Personalized treatment for gestational trophoblastic tumor -- 4 Personalized treatment in uterine sarcoma -- 5 Clinical relevance of brca1/2 pathogenic variants and impaired dna repair pathways in ovarian carcinomas -- 6 Personalized treatment in immunotherapy for gynecologic cancer -- 7 Risk assessment and prevention strategies for hereditary gynecological cancers -- 8 How genome-wide analysis contributes to personalized treatment in cancers including gynecologic cancers -- 9 Personalized treatment of gynecological cancer according to age and symptom benefit.
520 $a This book thoroughly illustrates the designed and tailored medical approaches for tumors of the female reproductive organ. The chapters explore different cancer species such as ovarian cancer, endometrial cancer, cervical cancer, etc. Various treatment modalities such as immunotherapy and histotype-specific treatment are delivered, and it offers a chapter on how genome-wide analysis contributes to personalized treatment. It is essential to understand this concept because many molecular target drugs and the prevalence of genome-based analysis in clinical settings have enabled us to introduce valid precision medicine in the field of gynecologic oncology. Chapters explain the stream of transition from conventional standardized treatment to personalized treatment and address future perspectives. Personalization Gynecologic Oncology is a well-designed source for beginning to advanced oncologists, gynecologists, geneticists, genetic counselors, and nurses. Offering the latest treatment strategies, the Editor hopes the ideas presented here will be a foundation for further development in the field. .
650 2 4 $a Tumour Biomarkers. $3 1391075
650 2 4 $a Cancer Genetics and Genomics. $3 1391074
650 2 4 $a Gynecology. $3 644094
650 0 $a Tumor markers. $3 679648
650 0 $a Cancer—Genetic aspects. $3 1391073
650 0 $a Gynecology . $3 1253939
650 0 $a Oncology. $3 593951
700 1 $a Mandai, Masaki. $e editor. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1391072
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9789811947100
776 0 8 $i Printed edition: $z 9789811947124
776 0 8 $i Printed edition: $z 9789811947131
830 0 $a Comprehensive Gynecology and Obstetrics, $x 2364-1932 $3 1285903
856 4 0 $u https://doi.org/10.1007/978-981-19-4711-7
912 $a ZDB-2-SME
912 $a ZDB-2-SXM
950 $a Medicine (SpringerNature-11650)
950 $a Medicine (R0) (SpringerNature-43714)